Otsuka Holdings Co., Ltd. logo

Otsuka Holdings Co., Ltd. (4578)

Market Closed
12 Jun, 06:00
JPX JPX
¥
10,200. 00
-20
-0.1957%
¥
4.67T Market Cap
28.4 P/E Ratio
140% Div Yield
1.77M Volume
0 Eps
¥ 10,220
Previous Close
Add Transaction
Day Range
10,125 10,310
Year Range
6,511 11,910
Want to track 4578 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4578 closed Friday lower at ¥10,200, a decrease of -0.1957% from Thursday's close, completing a monthly decrease of -11.1498% or -¥1,280. Over the past 12 months, 4578 stock gained 14.2985%.
4578 pays dividends to its shareholders, with the most recent payment made on Mar 01, 2026. The next announced payment will be in In 2 months on Sep 01, 2026 for a total of ¥69.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on JPX (JPY).

4578 Chart

People also search for

Chugai Pharmaceutical Co., Ltd.
¥ 7,450
+0.2962%
Daiichi Sankyo Co., Ltd.
¥ 2,546
+1.8196%
Fujifilm Holdings Corporation
¥ 3,439
+1.1173%
Astellas Pharma Inc
¥ 2,152.5
+0.5841%
Sysmex Corporation
¥ 1,421.5
+1.1384%

Otsuka Holdings Co., Ltd. (4578) FAQ

What is the stock price today?

The current price is ¥10,200.00.

On which exchange is it traded?

Otsuka Holdings Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 4578.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 140%.

What is its market cap?

As of today, the market cap is 4.67T.

Has Otsuka Holdings Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Otsuka Holdings Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Makoto Inoue CEO
JPX Exchange
JP3188220002 ISIN
Japan Country
35,338 Employees
29 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Otsuka Holdings Co., Ltd. is a global conglomerate headquartered in Tokyo, Japan, with a rich history dating back to its founding in 1921. The company operates through a diverse range of businesses including pharmaceuticals, nutraceuticals, consumer products, and others, catering to a worldwide market. Its commitment to innovation and development is evident in its extensive product portfolio which addresses a wide array of health and wellness needs.

Products and Services

  • Pharmaceutical Products: Development of drugs for psychiatry, neurology, oncology, cardiovascular and renal systems, digestive system, ophthalmology, and diagnostics. This includes intravenous solutions and medical devices, highlighting Otsuka's focus on addressing complex health issues across various medical fields.
  • Clinical Testing and Medical Equipment: Provision of services and tools for the healthcare industry, including devices and products that support the diagnosis and management of health conditions.
  • Consumer Products: A range of consumer-focused offerings, such as food products, cosmetics, functional food products, beverages including soft drinks and wine, nutritional products, and personal care items like insecticide and toiletry products, catering to everyday health and wellness needs.
  • Chemical and Industrial Products: Production and supply of chemical products, adhesive tapes, titanate compounds, synthetic resin molded products, paper products, and functional films, focusing on high-quality materials for various industrial applications.
  • IT Solutions and Services: Offering innovative technology solutions and services, including software and IT management services for mental healthcare systems, demonstrating Otsuka's integration of technology in healthcare.
  • Environmental & Health Services: Engaging in warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation, which underscore Otsuka's commitment to supporting healthcare logistics and innovation.
  • Nutraceuticals and Wellness Products: Development and marketing of health-focused products such as IV solutions, infusion and clinical nutrition products, hydrazine, plant-based food products, urinary tract health products, dietetic food, spring, and mineral water, and polyolefin foams, aimed at enhancing the quality of life.
  • Research, Development & Venture Activities: Involvement in tuberculosis research, xenotransplantation product development, anticancer drugs, terracess, bio-pesticides, as well as stable isotope production, showcasing Otsuka's dedication to advancing medical research and technologies.
  • Art and Design Services: Planning, design, production, and construction of artistic and architectural ceramics, including boards, walls, reliefs, terracotta, portraits, and sign boards, reflecting Otsuka's dedication to combining aesthetics with functionality.
  • Travel and Hospitality Services: Operation of travel agency services, and Hotel Ridge and California Table, extending Otsuka's reach into the travel and hospitality industry.

Contact Information

Address: 2-9 Kanda-Tsukasamachi
Phone: 81 3 6717 1410